CD19 CAR-T Therapy for Refractory Pemphigus Vulgaris
NCT07681388
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
3
Enrollment
OTHER
Sponsor class
Conditions
Pemphigus Vulgaris
Interventions
BIOLOGICAL:
Autologous CD19 CAR-T cells
Sponsor
Jinbo Chen